Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries
Langue
EN
Article de revue
Ce document a été publié dans
Vaccine. 2022-01-21, vol. 40, n° 2, p. 178-182
Résumé en anglais
France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes ...Lire la suite >
France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes towards a vaccine continue to deteriorate. The communication strategies of the government have not helped; in fact, they have made the situation worse. Empirical studies on the national strategy for management of the COVID-19 pandemic in France have shed light on the reasons for vaccine hesitancy. These studies have identified four pillars for the vaccination strategy: i) Communication regarding the importance of herd immunity, ii) making healthcare workers the focus of the vaccination campaign, iii) citizen mobilization and guaranteed consultations, and iv) access to free vaccines without delay. This paper discusses the evidence supporting this strategy.< Réduire
Mots clés en anglais
Models
Vaccine hesitancy
France
Covid-19
Project ANR
Etude des leviers permettant de maximiser la vaccination contre la Covid-19 dans la population adulte âgée de 18 à 64 ans à faible risque d'infection sévère - ANR-21-CO16-0006
Unités de recherche